En Es
Categories

DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tests are designed for hospital and private testing laboratories in the markets of immunodiagnostics and molecular diagnostics.
Products NewsSummary
Close

News of DIASORIN

DiaSorin to Acquire Siemens' ELISA Immunodiagnostics Business

01 Aug 2017
DiaSorin to Acquire Siemens' ELISA Immunodiagnostics Business
DiaSorin S.p.A. has entered into an agreement to acquire Siemens Healthineers’ micro-titre-based ELISA immunodiagnostic business portfolio and related tangible and intangible assets, including customer sales and distribution contracts, installed base of instruments and relevant intellectual property.
Read More
Close

About DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tests are designed for hospital and private testing laboratories in the markets of immunodiagnostics and molecular diagnostics.
FaceBook Twitter Google+ Linked in
Tuberclosis Assay

Tuberclosis Assay

Model: LIAISON QuantiFERON-TB Gold Plus
Request Information

Description:

The LIAISON QuantiFERON-TB Gold Plus is a fully automated CLIA assay to aid in the diagnosis of TB infection and can detect both active and latent TB infection. It is designed to work with QIAGEN Quantiferon-TB Gold Plus Blood Collection Tubes which employ TB-specific antigens that elicit both CD8+ and CD4+ T cell responses for accurate assessment of cell-mediated immune response to TB infection.


Send A Message To This Supplier

* Required Information
* Email
To
DIASORIN (Tuberclosis Assay)
* Message

Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions